Zolmitriptan brain targeting via intranasal route using solid lipid nanoparticles for migraine therapy: Formulation, characterization, in-vitro and in-vivo assessment
| dc.Affiliation | October University for modern sciences and Arts (MSA) | |
| dc.contributor.author | Mostafa, D.A.E | |
| dc.contributor.author | Khalifa, M.K.A | |
| dc.contributor.author | Gad, S.S | |
| dc.date.accessioned | 2020-03-19T07:21:54Z | |
| dc.date.available | 2020-03-19T07:21:54Z | |
| dc.date.issued | 2020-04 | |
| dc.description | Scopus | en_US |
| dc.description.abstract | Objective: Zolmitriptan, a class of antidepressant drugs with poor bioavailability due to its first-pass metabolism. The aim of this study was to improve systemic bioavailability and explore the brain targeting impact of nasal Zolmitriptan (Zol) solid lipid nanoparticles (SLNs) gel for migraine treatment. Methods: Stearic acid and cholesterol used as solid lipid and lecithin as a surfactant, emulsion solvent evaporation technique was used to produce Zolmitriptan SLNs. (Zol) SLNs were characterized for particle size, percent entrapment efficiency and in vitro drug release. Formula S6 showed greater percent entrapment efficiency (PEE), adequate particle size and sustained drug release behavior. Formula S6 was integrated into HPMC gel (3%) to prepare nasal gel. Zol SLN nasal gel was subjected to histopathological study to ensure brain targeting. Results: It was observed that all prepared Zol SLNs were in the nano-sized range with a polydispersity index of<0.5. In the cholesterol/lecithin combination, higher PEE%, better stability, and less agglomeration inclination were discovered. Results of the release profiles showed that developed Zol-SLNs were able to release Zolmitriptan in a sustained manner. Histopathological study of the brain tissues showed that Zolmitriptan SLN nasal gel can reach brain cells and localized for 24 h although the hydrophobicity of the target drug. Conclusion: Intranasal administration of Solid lipid nanostructure of Zolmitriptan through the olfactory pathway in which it travels from the nasal cavity to brain tissue achieved drug targeting potential of about 90% compared with conventional Zolmitriptan tablets. The small particle size helped them to squeeze themselves through the small opening in the olfactory neurons to the brain via different endo-cystic pathways of neuronal cells in nasal tissue membranes. © 2020 The Authors. | en_US |
| dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=19900192174&tip=sid&clean=0 | |
| dc.identifier.citation | Youssef, N.A.H.A., Kassem, A.A., Farid, R.M., Ismail, F.A., EL-Massik, M.A.E., Boraie, N.A. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation (2018) International Journal of Pharmaceutics, 548 (1), pp. 609-624. Cited 8 times. www.elsevier.com/locate/ijpharm doi: 10.1016/j.ijpharm.2018.07.014 View at Publisher 2 Wagh, M., Bora, S.M. Development and evaluation of elastic niosomal formulation for migraine treatment using TRNA approach (2018) Int J Pharm Sci Res, 9, pp. 4591-4600. Cited 2 times. 3 Raza, A., Ansari, T.M., Niazi, S.B. A novel spectrophotometric method for the determination of zolmitriptan in pharmaceutical formulations (2007) Journal of the Chinese Chemical Society, 54 (6), pp. 1413-1417. Cited 20 times. http://nr.stpi.org.tw/ejournal/ChiChemSociety/2007/EJ52-2007-1413.pdf doi: 10.1002/jccs.200700201 View at Publisher 4 Jain, R., Nabar, S., Dandekar, P., Vandana, P. Micellar nanocarriers: Potential nose-to-brain delivery of zolmitriptan as novel migraine therapy (2010) Pharmaceutical Research, 27 (4), pp. 655-664. Cited 55 times. doi: 10.1007/s11095-009-0041-x View at Publisher 5 Shiledar, R.R., Tagalpallewar, A.A., Kokare, C.R. Formulation and in vitro evaluation of xanthan gum-based bilayered mucoadhesive buccal patches of zolmitriptan (2014) Carbohydrate Polymers, 101 (1), pp. 1234-1242. Cited 41 times. doi: 10.1016/j.carbpol.2013.10.072 View at Publisher 6 Bayrak, Z., Tas, C., Tasdemir, U., Erol, H., Ozkan, C.K., Savaser, A., Ozkan, Y. Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: In vitro and in vivo evaluation (2011) European Journal of Pharmaceutics and Biopharmaceutics, 78 (3), pp. 499-505. Cited 37 times. doi: 10.1016/j.ejpb.2011.02.014 View at Publisher 7 Gupta, S., Kesarla, R., Chotai, N., Misra, A., Omri, A. Systematic approach for the formulation and optimization of solid lipid nanoparticles of efavirenz by high pressure homogenization using design of experiments for brain targeting and enhanced bioavailability (Open Access) (2017) BioMed Research International, 2017, art. no. 5984014. Cited 35 times. http://www.hindawi.com/journals/biomed/ doi: 10.1155/2017/5984014 View at Publisher 8 Pardridge, W.M. The blood-brain barrier: Bottleneck in brain drug development (Open Access) (2005) NeuroRx, 2 (1), pp. 3-14. Cited 1234 times. http://www.elsevierhealth.com doi: 10.1602/neurorx.2.1.3 View at Publisher 9 Singh, G.U., Rawat, N.I., Singh, K.I., Sarwal, A.M., Sinha, V.R. Investigating the potential of an antidepressant intranasal mucoadhesive microemulsion (2018) Int J Pharm Pharm Sci, 10, pp. 125-132. Cited 3 times. 10 Rodriguez, A., Tatter, S.B., Debinski, W. Neurosurgical techniques for disruption of the blood–brain barrier for glioblastoma treatment (Open Access) (2015) Pharmaceutics, 7 (3), pp. 175-187. Cited 38 times. http://www.mdpi.com/1999-4923/7/3/175/pdf doi: 10.3390/pharmaceutics7030175 View at Publisher 11 Begunm, M.Y., Gudipati, P.R. Formulaton and evalution of dasatinib loaded solid lipid nanoparticles (2018) Int J Pharm Pharm Sci, 10, pp. 15-20. 12 Jain, K., Sood, S., Gowthamarajan, K. Optimization of artemether-loaded NLC for intranasal delivery using central composite design (Open Access) (2015) Drug Delivery, 22 (7), pp. 940-954. Cited 32 times. doi: 10.3109/10717544.2014.885999 View at Publisher 13 Vijayan, V., Aafreen, S., Sakthivel, S., Reddy, K.R. Formulation and characterization of solid lipid nanoparticles loaded Neem oil for topical treatment of acne (2013) J Acute Disease, 2, pp. 282-286. Cited 21 times. 14 Garud, A., Singh, D., Garud, N. Solid lipid nanoparticles (SLN): Method, characterization and applications (2012) Int Curr Pharm J, 1, pp. 384-393. Cited 61 times. 15 Mukherjee, S., Ray, S., Thakur, R.S. Solid lipid nanoparticles: A modern formulation approach in drug delivery system (2009) Indian Journal of Pharmaceutical Sciences, 71 (4), pp. 349-358. Cited 259 times. doi: 10.4103/0250-474X.57282 View at Publisher 16 Shelke, S., Shahi, S., Jalalpure, S., Dhamecha, D. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies (2016) Journal of Liposome Research, 26 (4), pp. 313-323. Cited 20 times. doi: 10.3109/08982104.2015.1132232 View at Publisher 17 Panda, N., Reddy, A.V., Subba Reddy, G.V., Panda, K.C. Formulation design and in vitro evaluation of Zolmitriptan immediate release tablets using Primojel and AC-Di-Sol (2015) Journal of Pharmaceutical Sciences and Research, 7 (8), pp. 545-553. Cited 5 times. http://www.jpsr.pharmainfo.in/Documents/Volumes/vol7Issue08/jpsr07081510.pdf 18 Garud, A., Singh, D., Garud, N. Design and optimization of solid lipid nanoparticles (SLNs) of zolmitriptan for the management of migraine (2013) Ind J Pharm, 24, pp. 245-252. 19 Mostafa, D.A., Hashad, A.M., Abdelreheem, A.Y.M. Formulation and evaluation of novel brain targeting drug loaded in lipid-based nanoparticles through the intranasal route for Alzheimer (2019) Int Res J Pharm, 10, pp. 21-27. 20 Balguri, S.P., Adelli, G.R., Majumdar, S. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues (2016) European Journal of Pharmaceutics and Biopharmaceutics, 109, pp. 224-235. Cited 59 times. www.elsevier.com/locate/ejphabio doi: 10.1016/j.ejpb.2016.10.015 View at Publisher 21 Khalil, R.M., Abd-Elbary, A., Kassem, M.A. Formulation and characterization of nystatin-loaded nanostructured lipid carriers for topical delivery against cutaneous candidiasis (2013) BJPR, 4, pp. 490-512. Cited 14 times. 22 Fatouh, A.M., Elshafeey, A.H., Abdelbary, A. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: Formulation, optimization and in vivo pharmacokinetics (Open Access) (2017) Drug Design, Development and Therapy, 11, pp. 1815-1825. Cited 18 times. https://www.dovepress.com/getfile.php?fileID=37016 doi: 10.2147/DDDT.S102500 View at Publisher 23 Abd-Elal, R.M.A., Shamma, R.N., Rashed, H.M., Bendas, E.R. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency (Open Access) (2016) Drug Delivery, 23 (9), pp. 3374-3386. Cited 21 times. doi: 10.1080/10717544.2016.1183721 View at Publisher 24 Yassin, G.E., Amer, R.I., Fayez, A.M. Carbamazepine loaded vesicular structures for enhanced brain targeting via intranasal route: Optimization, in vitro evaluation, and in vivo study (Open Access) (2019) International Journal of Applied Pharmaceutics, 11 (4), pp. 264-274. https://innovareacademics.in/journals/index.php/ijap/article/download/33474/20373 doi: 10.22159/ijap.2019v11i4.33474 View at Publisher 25 Singh, S., Dobhal, A.K., Jain, A., Pandit, J.K., Chakraborty, S. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine (Open Access) (2010) Chemical and Pharmaceutical Bulletin, 58 (5), pp. 650-655. Cited 90 times. http://www.jstage.jst.go.jp/article/cpb/58/5/650/_pdf doi: 10.1248/cpb.58.650 View at Publisher 26 Kuo, Y.-C., Wang, C.-C. Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia (2013) Colloids and Surfaces B: Biointerfaces, 101, pp. 101-105. Cited 26 times. doi: 10.1016/j.colsurfb.2012.06.002 View at Publisher 27 Abdelbary, G.A., Amin, M.M., Zakaria, M.Y. Ocular ketoconazole-loaded proniosomal gels: Formulation, ex vivo corneal permeation and in vivo studies (Open Access) (2017) Drug Delivery, 24 (1), pp. 309-319. Cited 23 times. doi: 10.1080/10717544.2016.1247928 View at Publisher 28 Manjunath, K., Ready, J.S., Venkateswarlu, V. Solid lipid nanoparticles as drug delivery systems (2005) Methods and Findings in Experimental and Clinical Pharmacology, 27 (2), pp. 127-144. Cited 157 times. doi: 10.1358/mf.2005.27.2.876286 View at Publisher 29 Varshosaz, J., Ghaffari, S., Khoshayand, M.R., Atyabi, F., Azarmi, S., Kobarfard, F. Development and optimization of solid lipid nanoparticles of amikacin by central composite design (2010) Journal of Liposome Research, 20 (2), pp. 97-104. Cited 62 times. doi: 10.3109/08982100903103904 View at Publisher 30 Shah, R., Eldridge, D., Palombo, E., Harding, I. Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential (2014) Journal of Physical Science, 25 (1), pp. 59-75. Cited 60 times. http://web.usm.my/jps/25-1-14/25-1-4.pdf View at Publisher 31 Ruckmani, K., Sivakumar, M., Ganeshkumar, P.A. Methotrexate loaded Solid Lipid Nanoparticles (SLN) for effective treatment of carcinoma (2006) Journal of Nanoscience and Nanotechnology, 6 (9-10), pp. 2991-2995. Cited 65 times. doi: 10.1166/jnn.2006.457 View at Publisher 32 Asasutjarit, R., Lorenzen, S.-I., Sirivichayakul, S., Ruxrungtham, K., Ruktanonchai, U., Ritthidej, G.C. Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-hugag transfection (2007) Pharmaceutical Research, 24 (6), pp. 1098-1107. Cited 54 times. doi: 10.1007/s11095-007-9234-3 View at Publisher 33 Jain, S.K., Chourasia, M.K., Masuriha, R., Soni, V., Jain, A., Jain, N.K., Gupta, Y. Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery (Open Access) (2005) Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, 12 (4), pp. 207-215. Cited 71 times. doi: 10.1080/10717540590952591 View at Publisher 34 Severino, P., Andreani, T., Macedo, A.S., Fangueiro, J.F., Santana, M.H., Silva, A.M. Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery (2012) J Drug Delivery. Cited 118 times. 35 Vivek, K., Reddy, H., Murthy, R.S.R. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles (2007) AAPS PharmSciTech, 8 (4), art. no. 83. Cited 138 times. http://www.aapspharmscitech.org/articles/pt0804/pt0804083/pt0804083.pdf doi: 10.1208/pt0804083 View at Publisher 36 Muntimadugu, E., Dhommati, R., Jain, A., Challa, V.G.S., Shaheen, M., Khan, W. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease (2016) European Journal of Pharmaceutical Sciences, 92, pp. 224-234. Cited 62 times. www.elsevier.com/locate/ejps doi: 10.1016/j.ejps.2016.05.012 View at Publisher 37 Baig, M.S., Ahad, A., Aslam, M., Imam, S.S., Aqil, M., Ali, A. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity (2016) International Journal of Biological Macromolecules, 85, pp. 258-270. Cited 54 times. www.elsevier.com/locate/ijbiomac doi: 10.1016/j.ijbiomac.2015.12.077 View at Publisher 38 Müller, R.H., Mäder, K., Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art (2000) European Journal of Pharmaceutics and Biopharmaceutics, 50 (1), pp. 161-177. Cited 2422 times. doi: 10.1016/S0939-6411(00)00087-4 View at Publisher 39 El-Housiny, S., Eldeen, M.A.S., El-Attar, Y.A., Salem, H.A., Attia, D., Bendas, E.R., El-Nabarawi, M.A. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: Formulation and clinical study (Open Access) (2018) Drug Delivery, 25 (1), pp. 78-90. Cited 19 times. https://www.tandfonline.com/loi/idrd20 doi: 10.1080/10717544.2017.1413444 | en_US |
| dc.identifier.doi | https://doi.org/10.22159/ijap.2020v12i2.36812 | |
| dc.identifier.issn | 9757058 | |
| dc.identifier.other | https://doi.org/10.22159/ijap.2020v12i2.36812 | |
| dc.identifier.uri | https://t.ly/MROwZ | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Innovare Academics Sciences Pvt. Ltd | en_US |
| dc.relation.ispartofseries | International Journal of Applied Pharmaceutics;Volume 12, Issue 2, March-April 2020, Pages 86-93 | |
| dc.subject | university of Brain targeting | en_US |
| dc.subject | Histopathological examination | en_US |
| dc.subject | Migraine | en_US |
| dc.subject | Solid lipid nanoparticles (SLNs) | en_US |
| dc.subject | Zolmitriptan | en_US |
| dc.title | Zolmitriptan brain targeting via intranasal route using solid lipid nanoparticles for migraine therapy: Formulation, characterization, in-vitro and in-vivo assessment | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 51 B
- Format:
- Item-specific license agreed upon to submission
- Description: